PropertyValue
?:abstract
  • Fifteen pharmaceutical and life sciences companies will work with the Bill and Melinda Gates Foundation to accelerate the development of vaccines, diagnostics, and treatments for COVID-19 The group will share proprietary compound libraries, along with safety and activity data, with the COVID-19 Therapeutics Accelerator, an effort the foundation launched last month with Wellcome and Mastercard The 15 firms are also involved in other partnerships to develop COVID-19 therapies
?:creator
?:journal
  • C&EN_Global_Enterprise
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Drugmakers connect with Gates Foundation
?:type
?:who_covidence_id
  • #35171
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ehomnnj5>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ehomnnj5>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all